Myositis -specific and -associated antibodies in neurological disorders - A retrospective study of 727 patients
Testing MSA and MAA simultaneously may not be suitable as a primary screening method for myositis-linked diseases in clinical neurological groups. However, MSAs and MAAs may offer valuable diagnostic support, particularly in cases where myositis is strongly considered.
Authors
- Marcel Armbruster
- David Hoffmann
- Evelyn Dubois
- Justus Carl Marquetand (ORCID: https://orcid.org/0000-0002-2039-5498)
- Benedict Kleiser (ORCID: https://orcid.org/0000-0002-7575-0020)
- Markus C. Kowarik (ORCID: https://orcid.org/0000-0003-1389-5539)
- Alexander Grimm (ORCID: https://orcid.org/0000-0002-8615-5040)
Institutions
- Hertie Institute for Clinical Brain Research (DE)
- University of Tübingen (DE)
Publication Details
- Journal
- Journal of the Neurological Sciences
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1016/j.jns.2024.123213
- Citations
- 4
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- Eberhard Karls Universität Tübingen
- Medizinischen Fakultät, Eberhard Karls Universität Tübingen